Cycloalkyl alkanoic acids as integrin receptor antagonists
US6949578B2 · kind B2 · utility
3Cited by
1References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 14, 2004 |
| Grant date | Sep 27, 2005 |
| Priority date | — |
| Expiry date | Jul 14, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a class of compounds represented by the Formula I or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the αvβ3 and/or αvβ5 integrin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.